AMGN compared with TIL: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

TILInstil Bio, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

TILInstil Bio, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

TIL: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only TIL 2

AZNAstraZeneca Pharmaceuticalscustomer

—ImmuneOnco Biopharmaceuticals (Shanghai)unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

AMGN, solidTIL, dashed

AMGNAmgen Inc

460.67· pre 462.00· delayed

Mkt cap$249.4BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

TILInstil Bio, Inc.

6.58· pre 6.68· delayed

Pre-marketNov 4 '26delayed

Mkt cap$46.1MRevenue—Revenue—

Compare

Pre-marketNov 4 '26delayed

AMGNAmgen Inc

TILInstil Bio, Inc.

460.67pre 462.00delayed

Price

6.58pre 6.68delayed

$249.4B

Mkt cap

$46.1M

Q2 FY26$10.1B

Revenue

—

FY25$36.8B

Revenue

—

AMGN460.67vsTIL6.58Pre-marketNov 4 '26delayed